ARAsma Rafique

Asma Rafique

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Asma Rafique has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epigenomic Remodeling by Lipid Metabolism: A Cross-Disease Perspective on Cancer and Brain Disorders

    by Asma Rafique, Adeel Farooq, Clara E. Cho, Marica Bakovic

    Lipid metabolism is no longer viewed simply as a source of membrane biomass or ATP. It is now proposed as a regulatory system that determines which metabolites reach the nucleus, which chromatin-modifying enzymes are engaged, and which transcriptional states become stable during disease progression. This review develops a mechanistic cross-disease framework emphasizing metabolite flux, subcellular compartmentalization, cell-type specificity, and the temporal persistence of chromatin states. We synthesize recent evidence linking lipid metabolism to chromatin remodeling in cancer, Alzheimer’s disease, and Parkinson’s disease, and we highlight how emerging single-cell multi-omics and spatial lipidomics may shape potential metabolism-targeted epigenetic therapies. In both cancer and brain disorders, lipid flux alters the availability of acetyl-CoA, S-adenosylmethionine, NAD+, and bioactive fatty acid derivatives, thereby reshaping histone acetylation, DNA and histone methylation, chromatin accessibility, and transcription-factor activity. In cancer, de novo lipogenesis, acetate scavenging, fatty acid oxidation, and phospholipid remodeling sustain nuclear acetyl-CoA pools, promote oncogenic super-enhancers, and support survival under hypoxia, acidosis, and therapy stress. In neurodegenerative disease, mitochondrial dysfunction, cholesterol dyshomeostasis, sphingolipid imbalance, oxysterol accumulation, and microglial lipid droplet formation may distort the epigenetic programs required for neuronal maintenance, synaptic plasticity, and inflammatory resolution. However, neurodegenerative disorders are not uniformly hypoacetylated; instead, they exhibit stage-, region- and cell-type-specific chromatin remodeling, with hypoacetylation at some vulnerable loci coexisting with hyperacetylation at others. By comparing lipid–epigenome coupling across proliferative and degenerative conditions, we argue that the same metabolic nodes can yield markedly different pathological outcomes depending on cellular context, providing a basis for more precise therapeutic design.

  • Open Access

    Unannotated Genes in Genomics: Challenges, Opportunities, and AI Solutions

    by Adeel Farooq, Asma Rafique, Eunyoung Han

    The rapid proliferation of next-generation sequencing (NGS) technologies has generated an unprecedented volume of genomic data, yet a substantial fraction of these sequenced genomes remains functionally uncharacterized, a phenomenon collectively termed " genomic dark matter." Unannotated genes, including hypothetical proteins (HPs), orphan and de novo genes, small open reading frames (smORFs), and non-canonical ORFs (ncORFs), constitute 40–60% of bacterial genomes, approximately 30–35% of the human proteome, and up to 43% of metagenomic protein clusters. These uncharacterized sequences represent a critical bottleneck in translating genomic data into biological insight and biotechnological innovation. This review provides a comprehensive examination of the categories of unannotated genes, the systemic challenges that perpetuate the annotation gap, and the diverse biotechnological opportunities these sequences harbor across plant, animal, microbial, medical, and industrial domains. Critically, we evaluate the transformative role of artificial intelligence (AI) in bridging this gap, encompassing protein structure prediction tools such as AlphaFold2 and ESMFold, protein and genome language models including ESM2 and DNABERT-2, deep learning-based functional inference frameworks, and high-throughput experimental validation platforms such as CRISPR perturbomics and transposon-insertion sequencing (TIS). We argue that an integrative, AI-driven approach to functional genomics is not merely advantageous but essential for realizing the full potential of the genomic revolution.

  • Open Access

    Impact of Oxidative Stress-Driven Ferroptosis in Neurodegeneration

    by Asma Rafique, Aleena Junaid, Marica Bakovic

    Ferroptosis is an iron-dependent cell death driven by lipid peroxidation and failure of cellular antioxidant defenses. It is triggered by oxidative stress and can be aggravated by aging, inflammation, and dysregulation of iron homeostasis. In the central nervous system, iron dyshomeostasis, mitochondrial dysfunction, and membrane lipid remodeling can amplify oxidative injury and increase susceptibility to ferroptotic damage, particularly in vulnerable neurons. There is growing evidence that ferroptosis-related processes are linked to Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and Amyotrophic Lateral Sclerosis. This review addresses novel approaches to track ferroptosis in vivo, such as imaging and biomarker techniques, and important molecular mechanisms linking iron metabolism, reactive oxygen species, and PUFA-driven lipid peroxidation to neuronal damage. We also explore upstream transcriptional control via NRF2, iron chelation and iron-handling modulation, inhibition of lipid peroxidation, and reinforcement of the System Xc-GSH-GPX4 and CoQ10-linked defense pathways. Subsequently, we highlight translational issues that need attention to further progress ferroptosis-targeted therapies for neurodegenerative disease.


  • Open Access

    Impact of Oxidative Stress-Driven Ferroptosis in Neurodegeneration

    by Asma Rafique, Aleena Junaid, Marica Bakovic

    Ferroptosis is an iron-dependent cell death driven by lipid peroxidation and failure of cellular antioxidant defenses. It is triggered by oxidative stress and can be aggravated by aging, inflammation, and dysregulation of iron homeostasis. In the central nervous system, iron dyshomeostasis, mitochondrial dysfunction, and membrane lipid remodeling can amplify oxidative injury and increase susceptibility to ferroptotic damage, particularly in vulnerable neurons. There is growing evidence that ferroptosis-related processes are linked to Alzheimer's disease, Parkinson's disease, Huntington’s disease, and Amyotrophic Lateral Sclerosis. This review addresses novel approaches to track ferroptosis in vivo, such as imaging and biomarker techniques, and important molecular mechanisms linking iron metabolism, reactive oxygen species, and PUFA-driven lipid peroxidation to neuronal damage. We also explore upstream transcriptional control via NRF2, iron chelation and iron-handling modulation, inhibition of lipid peroxidation, and reinforcement of the System Xc-GSH-GPX4 and CoQ10-linked defense pathways. Subsequently, we highlight translational issues that need attention to further progress ferroptosis-targeted therapies for neurodegenerative disease.


  • Open Access

    Composite Genome Quality Index for Pathogenic Bacterial Genomes

    by Adeel Farooq, Asma Rafique

    High-quality bacterial genomes are essential for robust comparative genomics, reliable taxonomic assignment, and accurate pathogen and antimicrobial resistance (AMR) surveillance. Yet, public repositories still contain highly heterogeneous assemblies, and genome quality is often judged using single metrics in isolation. Here we develop an integrative Genome Quality Index (GQI) that combines four complementary metrics—including BUSCO single-copy completeness, contig number, N50, and unmapped read percentage—into a composite, interpretable score. We re-assembled and evaluated 474 pathogenic bacterial genomes submitted from South Korea using a standardized Illumina-based pipeline and validated the framework on an independent Enterobacteriaceae dataset (n = 5781). Species-level analyses and unsupervised clustering revealed pronounced variation in genome quality (one-way ANOVA, p < 1.05 × 10−33), with Cronobacter sakazakii and Listeria monocytogenes showing consistently high GQI scores, whereas Mycobacterium tuberculosis exhibited broad variability, including clear low-quality outliers. After log-transforming skewed variables, contig count and N50 remained strongly negatively correlated (r = −0.83), while BUSCO completeness showed moderate positive association with N50 and negative association with unmapped reads. GQI scores spanned 0.23–0.96, with most genomes clustering between 0.70 and 0.85. A Random Forest classifier trained on the four raw metrics predicted GQI-based quality tiers (low, medium, high) with 97% accuracy. From the top-decile genomes, we derived empirical thresholds like BUSCO ≥ 98.6%, contigs ≤ 30, N50 ≥ 1 Mb, and unmapped reads ≤ 0.82% that refine existing recommendations and provide actionable curation criteria. Our framework complements tools such as CheckM, gVolante, and Hybracter by offering a platform-agnostic composite scoring system that can be integrated into submission workflows and surveillance pipelines to systematically flag low-quality genomes and improve the reliability of microbial genomics.